The use of flow-diverter (FD) stents in recent years has positively changed the therapeutic approach to some vascular diseases, especially of certain types of aneurysms. This paper describes the case of a young patient after a major head trauma causing multiple skull fractures. The trauma occasioned two pseudoaneurysms from the A1 segment of the right anterior cerebral artery and from the A2 segment of the left anterior cerebral artery. Both lesions were treated with two Pipeline devices (ev3, Irvine, CA, USA) in two different sessions. The CT study and angiographic investigations performed in the following month showed a complete resolution of the post-traumatic pseudoaneurysmal lesions. Although the use of FD stents is described in the literature, particularly in the treatment of selected aneurysms, this paper shows good technical results in the use of these stents in cases of intracranial post-traumatic pseudoaneurysms with clinical improvement.
Introduction
The use of flow-diverter (FD) stents is well-established as an alternative treatment to the various techniques of coiling in aneurysmal complex lesions. Treatments with these devices in the literature are described in cases of aneurysm with unfavourable geometric relationships between the lesion and other vessels or when there is an artery emerging from the base of the aneurysm or in blister-like aneurysm.
Post-traumatic arterial lesions are often characterized by pseudoaneurysm (PSA) formation that tends to grow reducing the true vessel lumen and affecting distal perfusion. In this case, PSA involved two intracranial arteries. In order to restore vessel patency, we decided to use FD stents to treat these post-traumatic lesions.
Case Report
A 20-year-old male was assessed at our hospital after a trauma. The patient had major head injury with multiple basilar skull fractures. A CT scan showed extensive haemorrhage of frontal lobes bilaterally, intraventricular haemorrhage, pneumocephalus and diffuse post-traumatic cerebral oedema. Fracture of the clivus, ethmoid, sphenoid and orbital walls with bilateral orbital emphysema were also diagnosed ( Figure 1 ).
The patient was haemodynamically stabilized. CT angiography (CTA) was performed immediately after CT scan diagnosis of PSA of right anterior cerebral artery A1 segment and of left anterior cerebral artery A2 segment, both of 4 mm diameter. Chest abdomen CT scan did not show any lesions. At discharge, there were no focal deficits.
The three months CTA follow-up, compared with the first brain CTA, there was an increase in intracranial lesion volume, with maximum diameter around one centimetre ( Figure 2 ). Subsequently, the patient underwent digital subtraction angiography (DSA) that confirmed the presence of two PSAs; the first lesion was 11 mm and the second 7 mm. After this study, considering the PSA size increase and after waiting for the acute post-traumatic period, we decided to treat these lesions.
One month later, in an elective session, through right vascular femoral puncture and after endovascular navigation through the A2 tract of the right cerebral artery, a FD stent Pipeline (ev3, Irvine, CA, USA) 2.5 Â 12 mm was used to treat the first PSA at right anterior cerebral artery A1 segment. Two months after the first treatment, through the same access but in a different session another stent of the same type (Pipeline 2.5 Â 16 mm) was placed on left anterior cerebral artery A2 segment origin (Figures 3 to 5). No periprocedural or clinical complications occurred.
Dual antiplatelet therapy was used with Cardioaspirin 100 mg/die for five days and Tiklid 250 mg/die for seven days prior to treatment and then for a further 90 days from the first treatment, followed by six months of monotherapy.
The CTA study and angiographic investigations performed at six months after the second treatment showed a complete resolution of the pathological PSA ( Figure 6 ). In view of the technical success, the clinical outcome was optimal.
Discussion
Traumatic aneurysm results from a direct injury to the arterial wall or to acceleration-induced shear.
The vessels involved are cervical, cerebral or meningeal arteries. More than 50% of traumatic aneurysms are associated with skull fracture and the majority are false aneurysms. These lesions tend to develop within hours after trauma and may regress, thrombose, enlarge or rupture. Subarachnoid or intraparenchymal haemorrhage occurs in 60% of cases with an associated mortality of 50%. 1 Traumatic pseudoaneurysm (PSA) remains a rare lesion and represents one of the most difficult vascular lesions to treat either with open or endovascular techniques. 2 In case of a PSA lesion, the purpose is to reconstruct the anatomy of the vascular course, ensuring the patency of the affected artery with preservation (1) of the parent vessel. To achieve this goal, in this case a flow-diverter (FD) stent was used.
The literature reports several cases of various endovascular treatments in intracranial PSA. Lim et al. described a complete obliteration of a traumatic PSA of the supraclinoid internal carotid artery using stent-in-stent assisted coil embolization. 3 Medel et al. reported a case of traumatic orbitofrontal PSA treated with Onyx, a liquid embolic agent. 4 It should be specified that these lesions were different from those described in this case report. Van Rooij et al. described two successful cases: the first treating a post-traumatic aneurysm with glue and the second treating a post-traumatic PSA with microcoils. 5 In our case coils were not an option, not only because of the morphology of the aneurysm, but also because of intramural thrombus, the poor quality of the wall and because parent vessel sacrifice was not feasible without expecting ischemic complications.
The FD stent is a useful device for endovascular treatment of different intracranial vessel lesions, including unruptured aneurysms. 6 Like the traditional endosaccular treatment of cerebral aneurysms with coil embolization, there is also the possibility to use FD stent in complex wide-necked aneurysms or very large and giant aneurysms.
The feasibility of the concept of preliminary endoluminal reconstruction (rather than endosaccular filling) to achieve aneurysm occlusion was demonstrated in the 1990s by the seminal work of several investigators who implanted stents across the necks of experimental aneurysms with and without endosaccular embolization coils or liquid polymers. 7 Reconstruction by means of endovascular stent placement represents an important advance in the ongoing development of endovascular remodelling strategies for aneurysm treatment, demonstrating favourable results in varied studies. [8] [9] [10] [11] The results of several series demonstrate that Pipeline can be a useful device for the treatment of wide-necked, fusiform, and previously incompletely treated aneurysms. 12 Haemodynamic studies in the literature proved the stent-induced reduction of aneurysmal inflow leading to changes in wall shear stress at the aneurysm dome. [13] [14] The procedure is generally safer than coil embolization due to elimination of the risks entailed in direct manipulation of the aneurysm sac with the microcatheter and coil mass. 15 Aneurysms of the non-branching supraclinoid portion of the internal carotid artery are commonly known as blister-like aneurysms, and are characterized as fragile and having a ''false'' wall without a well-defined neck. Three cases have been reported in the literature on the use of FD stents in blister-like aneurysms. In those cases, where the recommended therapy is reconstruction of the vessel wall, FD stents seem to be the only endovascular device capable of this task. 16, 17 The objective of reducing inflow and intrasaccular pressure leading to a slow and progressive thrombosis of false aneurysms with a complete endothelialization of the FD stent was reached. Since both catheterization and endosaccular coil placement carry an increased risk of procedural rupture especially in very small and blister aneurysms located at curve vessels, FD implantation offers an option to treat such aneurysms without wall contact, that should reduce the risk of periprocedural rupture. 18 FD stents were used also in intracranial dissection and the results in these cases show that vessel reconstruction with this device can be achieved instantaneously. Fisher et al. reported successful results using an FD stent in a five-vessel dissection without complications. 12 Our study reported the use of an FD stent in treatment of bilateral post-traumatic anterior cerebral artery PSA. Martin et al described a case of treatment with an FD stent of an A1/A2 junction dissecting-type aneurysm in a 38-year-old man presenting with subarachnoid haemorrhage. In that case, final control injections confirmed no filling of the aneurysm with wide patency of the parent vessel and covered side branches. 17 Treatment of a basilar artery PSA after traumatic atlanto-occipital dislocation in a seven-yearold girl was performed with coiling and stent positioning. 19 Other cases of intracranial and extracranial internal carotid PSA were treated successfully with an FD stent. 1, 18, 20 There are no data-driven guidelines on optimal antiplatelet therapy (APT). Most of the time, the patient takes dual APT for five to seven days prior to treatment and is maintained on dual APT for three to six months followed by six months or lifelong monotherapy. In practice, the indication varies depending on lesion location and parent artery vessel stenosis. [21] [22] Flow-diverter stenting of post-traumatic bilateral anterior cerebral artery pseudoaneurysm in our case proved safe and effective in the reconstruction of the vessels and subsequent imaging controls showed the patency of cerebral arteries. Complete endothelialization of the correctly positioned stent was observed.
Conclusion
This case report shows good results in the use of a flowdiverter stent even in cases of no bleeding intracranial pseudoaneurysms. In particular, it was possible to obtain symptom resolution in a few months after endovascular treatment without the placement of microcoils that would have resulted in this case in a higher intraoperative risk. 
